A real‐world, non‐interventional, prospective study of the effectiveness and safety of apremilast in bio‐naïve adults with moderate plaque psoriasis treated in the routine care in Greece – the ‘ <scp>APRAISAL</scp> ’ study-Reference-Cited by-同舟云学术

A real‐world, non‐interventional, prospective study of the effectiveness and safety of apremilast in bio‐naïve adults with moderate plaque psoriasis treated in the routine care in Greece – the ‘ APRAISAL ’ study

Published:2022-05-21 Issue:11 Volume:36 Page:2055-2063
ISSN:0926-9959
Container-title:Journal of the European Academy of Dermatology and Venereology
language:en
Short-container-title:Acad Dermatol Venereol

Author:

Ioannides D.¹^ORCID,Antonakopoulos N.²,Chasapi V.³,Oikonomou C.⁴,Tampouratzi E.⁵^ORCID,Lazaridou E.⁶,Rigopoulos D.⁷^ORCID,Neofotistou O.⁸,Drosos A.⁹,Anastasiadis G.¹⁰,Rovithi E.¹¹,Kalinou C.¹²,Papadavid E.¹³^ORCID,Aronis P.¹⁴,Papageorgiou M.¹⁵,Protopapa A.¹⁶,Bassukas I.¹⁷,Lefaki I.¹⁸,Zafiriou E.¹⁹^ORCID,Krasagakis K.²⁰,Pokas E.²¹,Anagnostopoulos Z.²²^ORCID,Kekki A.²^ORCID,Papakonstantis M.²³

Affiliation:

1. 1st University Department of Dermatology Aristotle University of Thessaloniki, Hospital for Venereal & Skin Diseases of Thessaloniki Thessaloniki Greece

2. Genesis Pharma Halandri Greece

3. Dermatology and Venereology Department of N.H.S “Andreas Sygros” Hospital Athens Greece

4. Department of Dermatology University General Hospital of Patras Patras Greece

5. Dermatology Unit Piraeus Regional General Hospital “Tzaneio” Piraeus Greece

6. 2nd University Department of Dermatology Aristotle University of Thessaloniki “Papageorgiou” General Hospital of Thessaloniki Thessaloniki Greece

7. 1st Department of Dermatology & Venereology National Kapodistrian University of Athens, “Andreas Sygros” Hospital Athens Greece

8. Dermatology Department “Konstantopoulio” District General Hospital of Nea Ionia Nea Ionia Greece

9. Department of Dermatology General Hospital of Xanthi Xanthi Greece

10. Department of Dermatology “Evaggelismos” General Hospital of Athens Athina Greece

11. Department of Dermatology and Venereology “Venizeleio‐ Pananeio” General Hospital of Heraklion Heraklion Greece

12. Outpatient Department of Dermatology “Agios Pavlos” General Hospital of Thessaloniki Thessaloniki Greece

13. 2nd Department of Dermatology & Venereology National Kapodistrian University of Athens, “Attikon” University General Hospital Athens Greece

14. Clinical Dermatology Hellenic Airforce 251 General Hospital Athens Greece

15. State Department of Dermatology Hospital for Venereal & Skin Diseases of Thessaloniki Thessaloniki Greece

16. Outpatient Department of Dermatology General Hospital of Sitia Sitia Greece

17. Department of Skin and Venereal Diseases University of Ioannina Ioannina Greece

18. Dermatology Unit “EUROMEDICA” General Clinic Thessaloniki Greece

19. University Clinic of Dermatology University General Hospital of Larissa Larissa Greece

20. Department of Dermatology University General Hospital of Heraklion Heraklion Greece

21. Outpatient Department of Dermatology “KAT” General Hospital of Attica Athens Greece

22. Formely at Genesis Pharma Halandri Greece

23. Clinic of Dermatology 401 General Military Hospital of Athens Athens Greece

Funder

Celgene

Genesis Pharma

Publisher

Wiley

Subject

Infectious Diseases,Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jdv.18166

Reference44 articles.

1. Global Epidemiology of Psoriasis: A Systematic Review of Incidence and Prevalence

2. Epidemiology of psoriasis;Fernández‐Armenteros JM;A Population‐Based Study Actas Dermosifiliogr,2019

3. Quality of Life and Work Productivity Impairment among Psoriasis Patients: Findings from the National Psoriasis Foundation Survey Data 2003–2011

4. Patient perceptions of clear/almost clear skin in moderate-to-severe plaque psoriasis: results of the Clear About Psoriasis worldwide survey

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long‐term effectiveness and tolerability of apremilast in patients with moderate‐to‐severe plaque psoriasis: A 5‐year multicentre retrospective study—IL PSO (Italian landscape psoriasis);Journal of the European Academy of Dermatology and Venereology;2024-03-29

2. Improved Quality of Life in Patients with Psoriasis Receiving Apremilast: Real-World Data from the Netherlands;Advances in Therapy;2024-02-24

3. Efficacy of tyrosine-kinase-2 and phosphodiesterase-4 inhibitors for scalp psoriasis: a systematic review and meta-analysis;Current Medical Research and Opinion;2023-12-13

4. Apremilast;Reactions Weekly;2023-06-10

5. Apremilast treatment of plaque psoriasis (PsO) after systemic therapy in Spanish clinical practice: Data from the APPROPRIATE study;JEADV Clinical Practice;2023-05-24